Page last updated: 2024-11-03

procarbazine and Dyskinesia, Medication-Induced

procarbazine has been researched along with Dyskinesia, Medication-Induced in 1 studies

Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Iure, A1
Napolitano, F1
Beck, G1
Quiroga Varela, A1
Durante, V1
Sciaccaluga, M1
Mazzocchetti, P1
Megaro, A1
Tantucci, M1
Cardinale, A1
Punzo, D1
Mancini, A1
Costa, C1
Ghiglieri, V1
Tozzi, A1
Picconi, B1
Papa, SM1
Usiello, A1
Calabresi, P1

Other Studies

1 other study available for procarbazine and Dyskinesia, Medication-Induced

ArticleYear
Striatal spreading depolarization: Possible implication in levodopa-induced dyskinetic-like behavior.
    Movement disorders : official journal of the Movement Disorder Society, 2019, Volume: 34, Issue:6

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Antiparkinson Agents; Corpus Striatum; Dopa

2019